Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.

Saved in:
Bibliographic Details
Title: Metabolomic profile differs between LADA and type 1 diabetes identifying tryptophan metabolism as a pathway involved in the heterogeneity of autoimmune diabetes.
Authors: Maddaloni E; Department of Experimental Medicine, Sapienza University, Rome, Italy., Pezzica S; Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy., Amendolara R; Department of Experimental Medicine, Sapienza University, Rome, Italy., Sabatini S; Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy., Mocciaro G; Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy., Sebastiani G; Diabetes Research Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario ONLUS, Toscana Life Science, Siena, Italy., D'Onofrio L; Department of Experimental Medicine, Sapienza University, Rome, Italy., Carli F; Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy., Tesi M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Suleiman M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Navarini L; Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Bio-Medico School of Medicine, Rome, Italy., Nigi L; Diabetes Research Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario ONLUS, Toscana Life Science, Siena, Italy., Formichi C; Diabetes Research Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario ONLUS, Toscana Life Science, Siena, Italy., Vomero M; Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Minerba M; Rheumatology and Clinical Immunology, Department of Medicine, University of Rome Campus Bio-Medico School of Medicine, Rome, Italy., Marchetti P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Dotta F; Diabetes Research Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.; Fondazione Umberto Di Mario ONLUS, Toscana Life Science, Siena, Italy.; Tuscany Centre for Precision Medicine (CReMeP), Siena, Italy., Buzzetti R; Department of Experimental Medicine, Sapienza University, Rome, Italy. raffaella.buzzetti@uniroma1.it., Gastaldelli A; Cardiometabolic Risk Unit, Institute of Clinical Physiology-National Research Council, Pisa, Italy. amalia.gastaldelli@cnr.it.
Source: Diabetologia [Diabetologia] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0428
DOI:10.1007/s00125-026-06777-4